13F
中

ZVRA ZEVRA THERAPEUTICS INC

2026Q1 · CUSIP 488445206 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
147
Δ holders QoQ
-11
Breadth percentile
Top 87%
Whale holders
76
Δ whales
-5
Inst. holding value
$381M
New positions
20
Closed positions
31
Price momentum (1Q)
+21.4%
Put / Call
4/6

Breadth history (34 quarters)

2021Q1: Δ+50 · h=51 2021Q2: Δ+20 · h=71 2021Q3: Δ+0 · h=71 2021Q4: Δ+7 · h=78 2022Q1: Δ+4 · h=82 2022Q2: Δ-9 · h=73 2022Q3: Δ-4 · h=69 2022Q4: Δ+2 · h=71 2023Q1: Δ-10 · h=61 2023Q2: Δ+10 · h=71 2023Q3: Δ+7 · h=78 2023Q4: Δ+7 · h=85 2024Q1: Δ+4 · h=89 2024Q2: Δ+5 · h=94 2024Q3: Δ+15 · h=109 2024Q4: Δ+3 · h=112 2025Q1: Δ+0 · h=112 2025Q2: Δ+10 · h=122 2025Q3: Δ+44 · h=166 2025Q4: Δ-8 · h=158 2026Q1: Δ-11 · h=147 2021Q1: holders=51 2021Q2: holders=71 2021Q3: holders=71 2021Q4: holders=78 2022Q1: holders=82 2022Q2: holders=73 2022Q3: holders=69 2022Q4: holders=71 2023Q1: holders=61 2023Q2: holders=71 2023Q3: holders=78 2023Q4: holders=85 2024Q1: holders=89 2024Q2: holders=94 2024Q3: holders=109 2024Q4: holders=112 2025Q1: holders=112 2025Q2: holders=122 2025Q3: holders=166 2025Q4: holders=158 2026Q1: holders=147 -50 -25 +0 +25 +50 45110175 21Q121Q322Q122Q323Q123Q324Q124Q325Q125Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 5% -3.2% +11.5%
2021Q2 Top 14% — —
2021Q1 Top 4% — —

Options Sentiment

Put holders
4
QoQ: 0
Call holders
6
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
6.6
EPS (TTM)
$2.01
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+201.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1M 2022-09-30: $3M 2022-12-31: $2M 2023-03-31: $3M 2023-06-30: $8M 2023-09-30: $3M 2023-12-31: $13M 2024-03-31: $3M 2024-06-30: $4M 2024-09-30: $4M 2024-12-31: $12M 2025-03-31: $20M 2025-06-30: $26M 2025-09-30: $26M 2025-12-31: $34M 2026-03-31: $36M 2022-06-30: EPS -0.70 2022-09-30: EPS -0.19 2022-12-31: EPS 0.16 2023-03-31: EPS -0.38 2023-06-30: EPS -0.08 2023-09-30: EPS -0.30 2023-12-31: EPS -0.54 2024-03-31: EPS -0.40 2024-06-30: EPS -0.48 2024-09-30: EPS -0.69 2024-12-31: EPS -0.71 2025-03-31: EPS -0.06 2025-06-30: EPS 1.21 2025-09-30: EPS -0.01 2025-12-31: EPS 0.21 2026-03-31: EPS 0.60 0M 18M 36M $M -0.78 0.27 1.33 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 6 2025-09-30: PE 20.72025-12-31: PE 6.32026-03-31: PE 5.5 5 13 22 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)